These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 7867192)

  • 1. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients.
    Leenhardt A; Lucet V; Denjoy I; Grau F; Ngoc DD; Coumel P
    Circulation; 1995 Mar; 91(5):1512-9. PubMed ID: 7867192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catecholaminergic polymorphic ventricular tachycardia. An important diagnosis in children with syncope and normal heart.
    Leite LR; Ponzi Pereira KR; Alessi SR; de Paola AA
    Arq Bras Cardiol; 2001 Jan; 76(1):63-74. PubMed ID: 11175485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Catecholaminergic polymorphic ventricular tachycardia in a child: an often unrecognized diagnosis].
    Massin M; Leroy P; Misson JP; Lepage P
    Arch Pediatr; 2003 Jun; 10(6):524-6. PubMed ID: 12915016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long term course of catecholaminergic polymorphic ventricular tachycardia in children. Apropos of 20 cases with an 8 year-follow-up].
    Lucet V; Grau F; Denjoy I; Do Ngoc D; Geiger K; Ghisla R; Mselati JC; Leenhardt A; Coumel P
    Arch Pediatr; 1994 Jan; 1(1):26-32. PubMed ID: 7916243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experiences of patients with catecholaminergic polymorphic ventricular tachycardia.
    Celiker A; Erdoğan I; Karagöz T; Ozer S
    Cardiol Young; 2009 Feb; 19(1):45-52. PubMed ID: 19102802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.
    Sy RW; Gollob MH; Klein GJ; Yee R; Skanes AC; Gula LJ; Leong-Sit P; Gow RM; Green MS; Birnie DH; Krahn AD
    Heart Rhythm; 2011 Jun; 8(6):864-71. PubMed ID: 21315846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exertion syncopal crisis in the young, associated with idiopathic long QT syndrome].
    Mesquita A; Almeida M; Adragão P; Neves J; Morgado F; Parreira L; Nascimento R; Araújo JJ; Mendes M; Bonhorst D; Martins M; Seabra-Gomes R
    Rev Port Cardiol; 1996 Jan; 15(1):45-55. PubMed ID: 8703503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol.
    De Rosa G; Delogu AB; Piastra M; Chiaretti A; Bloise R; Priori SG
    Pediatr Emerg Care; 2004 Mar; 20(3):175-177. PubMed ID: 15094576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise-induced bidirectional ventricular tachycardia with alternating right and left bundle branch block-type patterns--a case report.
    Khan IA
    Angiology; 2002; 53(5):593-8. PubMed ID: 12365869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with β1-selective β-blockers in patients with catecholaminergic polymorphic ventricular tachycardia.
    Leren IS; Saberniak J; Majid E; Haland TF; Edvardsen T; Haugaa KH
    Heart Rhythm; 2016 Feb; 13(2):433-40. PubMed ID: 26432584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.
    Bergeman AT; Lieve KVV; Kallas D; Bos JM; Rosés I Noguer F; Denjoy I; Zorio E; Kammeraad JAE; Peltenburg PJ; Tobert K; Aiba T; Atallah J; Drago F; Batra AS; Brugada R; Borggrefe M; Clur SB; Cox MGPJ; Davis A; Dhillon S; Etheridge SP; Fischbach P; Franciosi S; Haugaa K; Horie M; Johnsrude C; Kane AM; Krause U; Kwok SY; LaPage MJ; Ohno S; Probst V; Roberts JD; Robyns T; Sacher F; Semsarian C; Skinner JR; Swan H; Tavacova T; Tisma-Dupanovic S; Tfelt-Hansen J; Yap SC; Kannankeril PJ; Leenhardt A; Till J; Sanatani S; Tanck MWT; Ackerman MJ; Wilde AAM; van der Werf C
    Circulation; 2023 Dec; 148(25):2029-2037. PubMed ID: 37886885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia.
    Peltenburg PJ; Kallas D; Bos JM; Lieve KVV; Franciosi S; Roston TM; Denjoy I; Sorensen KB; Ohno S; Roses-Noguer F; Aiba T; Maltret A; LaPage MJ; Atallah J; Giudicessi JR; Clur SB; Blom NA; Tanck M; Extramiana F; Kato K; Barc J; Borggrefe M; Behr ER; Sarquella-Brugada G; Tfelt-Hansen J; Zorio E; Swan H; Kammeraad JAE; Krahn AD; Davis A; Sacher F; Schwartz PJ; Roberts JD; Skinner JR; van den Berg MP; Kannankeril PJ; Drago F; Robyns T; Haugaa K; Tavacova T; Semsarian C; Till J; Probst V; Brugada R; Shimizu W; Horie M; Leenhardt A; Ackerman MJ; Sanatani S; van der Werf C; Wilde AAM
    Circulation; 2022 Feb; 145(5):333-344. PubMed ID: 34874747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers.
    Mazzanti A; Kukavica D; Trancuccio A; Memmi M; Bloise R; Gambelli P; Marino M; Ortíz-Genga M; Morini M; Monteforte N; Giordano U; Keegan R; Tomasi L; Anastasakis A; Davis AM; Shimizu W; Blom NA; Santiago DJ; Napolitano C; Monserrat L; Priori SG
    JAMA Cardiol; 2022 May; 7(5):504-512. PubMed ID: 35353122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Catecholinergic ventricular tachycardia in children].
    Denjoy I; Postma A; Lupoglazoff JM; Vaksman G; Kamblock J; Leenhardt A; Wilde AA; Guicheney P
    Arch Mal Coeur Vaiss; 2005 May; 98(5):506-12. PubMed ID: 15966600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent?
    Ackerman MJ; Priori SG; Dubin AM; Kowey P; Linker NJ; Slotwiner D; Triedman J; Van Hare GF; Gold MR
    Heart Rhythm; 2017 Jan; 14(1):e41-e44. PubMed ID: 27659101
    [No Abstract]   [Full Text] [Related]  

  • 16. Catecholaminergic Polymorphic Ventricular Tachycardia with QT Prolongation.
    Tanaka Y; Kawabata M; Scheinman MM; Hirao K
    Pacing Clin Electrophysiol; 2015 Dec; 38(12):1499-502. PubMed ID: 26256814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical challenges in the management of catecholaminergic polymorphic ventricular tachycardia in children].
    Ge HY; Li XM; Jiang H; Zhang Y; Liu HJ; Zheng XC; Li MT
    Zhonghua Er Ke Za Zhi; 2017 Dec; 55(12):926-931. PubMed ID: 29262473
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia.
    Hayashi M; Denjoy I; Extramiana F; Maltret A; Buisson NR; Lupoglazoff JM; Klug D; Hayashi M; Takatsuki S; Villain E; Kamblock J; Messali A; Guicheney P; Lunardi J; Leenhardt A
    Circulation; 2009 May; 119(18):2426-34. PubMed ID: 19398665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mid-term clinical condition and prognosis in adrenergic ventricular tachycardia in children with apparently normal hearts].
    Drago F; Vignati G; Agostino DA; Mauri L; Calzolari A; Figini A; Ragonese P
    G Ital Cardiol; 1997 Apr; 27(4):349-56. PubMed ID: 9244739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.
    Khoury A; Marai I; Suleiman M; Blich M; Lorber A; Gepstein L; Boulos M
    Heart Rhythm; 2013 Nov; 10(11):1671-5. PubMed ID: 23954267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.